About Alleviate Pharmaceuticals
Alleviate Pharmaceuticals is a Healthcare company. Manufacturing and supplying pharmaceutical products, including tablets, capsules, and franchise services in India. Its Indian entity Alleviate Pharmaceuticals Private Limited reported revenue of ₹1.02 Cr. Alleviate Pharmaceuticals offers products and services including Pharmaceutical Tablets and PCD Pharma Franchise. Its focus areas include Pharmaceuticals, Franchise and Distribution, PCD Pharma Services and Drug Manufacturing.
Company details
Alleviate Pharmaceuticals is recognized for its focus on delivering high-quality pharmaceutical medicines and healthcare products for all age groups. Products such as tablets, capsules, injections, and Ayurvedic items are manufactured and supplied in accordance with GMP and WHO standards. Services including PCD Pharma Franchise and Third Party Manufacturing are offered to support distribution and marketing efforts. Quality is maintained through the use of effective ingredients, while client satisfaction is prioritized by meeting industry norms and ensuring product reliability. A technically sound team is employed to handle challenges in the competitive market.
- SectorsHealthcare
- Email••••••••
- Legal Name Alleviate Pharmaceuticals Pvt. Ltd.
- Date of Incorporation 05 Jan, 2015
- Jurisdiction Panchkula, Haryana, India
- Indian entity revenue₹1.02 Cr
FY 2025 · -8% YoY
- Indian entity net profit₹1.8 Lakh
FY 2025 · 2% margin
- Indian entity EBITDA₹6.8 Lakh
FY 2025 · 7% margin
Associated legal entities of Alleviate Pharmaceuticals
Alleviate Pharmaceuticals operates through Alleviate Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Alleviate Pharmaceuticals Private Limited CIN U24232HR2015PTC077954 | Active | 05 Jan 2015 | Panchkula, Haryana | ₹1.0 Cr | 2 | View details |
Products & Services of Alleviate Pharmaceuticals
Alleviate Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Tablets and PCD Pharma Franchise.
Tablets are manufactured and supplied for various health needs, ensuring accurate composition and adherence to industry norms.
Franchise opportunities are provided for distributing pharmaceutical products on a district-wise monopoly basis.
Board of directors of Alleviate Pharmaceuticals Private Limited (Alleviate Pharmaceuticals)
Alleviate Pharmaceuticals Private Limited is the primary company behind Alleviate Pharmaceuticals. The board of Alleviate Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Sanjiv Kumar, appointed in 2015. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjiv Kumar DIN 07048016 | Director | 05 Jan 2015 | 11 yrs 9 mo | Alleviate Pharmaceuticals Private Limited |
| Maheepal DIN 07301121 | Director | 08 Oct 2015 | 11 yrs | Alleviate Pharmaceuticals Private Limited |
Financials of Alleviate Pharmaceuticals
Figures of Alleviate Pharmaceuticals Private Limited, the primary company behind Alleviate Pharmaceuticals, for FY 2025. Revenue was ₹1.02 Cr (-8% year on year). Net profit was ₹1.8 Lakh (2% margin). EBITDA was ₹6.8 Lakh (7% margin). Revenue has grown at a compounded annual rate of -9% over three years and -12% over five years.
- ₹1.02 CrRevenue · FY 2025 · -8% YoY
- ₹1.8 LakhNet profit · 2% margin
- ₹6.8 LakhEBITDA · 7% margin
- ₹10 LakhPaid-up capital
- -9%Revenue CAGR, 3 years
- -12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Alleviate Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Alleviate Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Alleviate Pharmaceuticals
The primary company behind Alleviate Pharmaceuticals, Alleviate Pharmaceuticals Private Limited, reported revenue of ₹1.02 Cr for FY 2025, down 8% year on year.
Alleviate Pharmaceuticals is recognized for its focus on delivering high-quality pharmaceutical medicines and healthcare products for all age groups. Products such as tablets, capsules, injections, and Ayurvedic items are manufactured and supplied in accordance with GMP and WHO standards. Services including PCD Pharma Franchise and Third Party Manufacturing are offered to support distribution and marketing efforts. Quality is maintained through the use of effective ingredients, while client satisfaction is prioritized by meeting industry norms and ensuring product reliability. A technically sound team is employed to handle challenges in the competitive market.
Alleviate Pharmaceuticals offers Pharmaceutical Tablets and PCD Pharma Franchise.
Alleviate Pharmaceuticals operates through Alleviate Pharmaceuticals Private Limited.
The legal entities of Alleviate Pharmaceuticals currently have 2 directors, including Maheepal, Sanjiv Kumar.